Gerrit Hauck
Vermogen: 652 192 $ op 31-05-2026
Vermogen: 652 192 $ op 31-05-2026
Dr. Gerrit Hauck is a Chief Technology Officer at Basilea Pharmaceutica AG.
He is on the Board of Directors at Basilea Pharmaceutica China Ltd. He received his undergraduate degree from Ruprecht-Karls-Universität Heidelberg and a doctorate degree from Universität des Saarlandes.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 9.781 ( 0,07% ) | 652 192 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 |
Basilea Pharmaceutica China Ltd.
Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of anti-infective and anti-cancer drugs | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität des Saarlandes
Universität des Saarlandes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Basilea Pharmaceutica China Ltd.
Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of anti-infective and anti-cancer drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau